The effects of vagus nerve stimulation on pro- and anti-inflammatory cytokines in children with refractory epilepsy: An exploratory study

NeuroImmunoModulation

Volumn 19, Issue 6, 2012, Pages 352-358

  Aalbers, Marlien Wilhelmina ^a,b   Klinkenberg, Sylvia ^b,c   Rijkers, Kim ^a,b   Verschuure, Pauline ^c   Kessels, Alfons ^b   Aldenkamp, Albert ^b,c   Vles, Johan ^a,b   Majoie, Marian ^a,b,c  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c EPILEPSY CENTER KEMPENHAEGHE   (Netherlands)

Author keywords

Children; Cholinergic anti inflammatory pathway; Cytokines; Epilepsy; Inflammation; Vagus nerve stimulation

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6;

ADOLESCENT; ARTICLE; CEREBROSPINAL FLUID; CHILD; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EPILEPSY; EXPLORATORY RESEARCH; FEMALE; HUMAN; MALE; PREDICTIVE VALUE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; VAGUS NERVE STIMULATION;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CYTOKINES; DOUBLE-BLIND METHOD; EPILEPSY; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MALE; TREATMENT OUTCOME; VAGUS NERVE STIMULATION;

EID: 84866905471     PISSN: 10217401     EISSN: 14230216     Source Type: Journal    
DOI: 10.1159/000341402     Document Type: Article

References (41)

1. Schachter SC: Vagus nerve stimulation: mood and cognitive effects. Epilepsy Behav 2004; 5(suppl 1):S56-S59.
2. Ben-Menachem E, Manon-Espaillat R, Ristanovic R, Wilder BJ, Stefan H, Mirza W, Tarver WB, Wernicke JF: Vagus nerve stimulation for treatment of partial seizures. 1. A controlled study of effect on seizures-First International Vagus Nerve Stimulation Study Group. Epilepsia 1994; 35: 616-626.
3. Handforth A, DeGiorgio CM, Schachter SC, Uthman BM, Naritoku DK, Tecoma ES, Henry TR, Collins SD, Vaughn BV, Gilmartin RC, Labar DR, Morris GL 3rd, Salinsky MC, Osorio I, Ristanovic RK, Labiner DM, Jones JC, Murphy JV, Ney GC, Wheless JW: Vagus nerve stimulation therapy for partialonset seizures: a randomized active-control trial. Neurology 1998; 51: 48-55.
4. A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures-the Vagus Nerve Stimulation Study Group. Neurology 1995; 45: 224-230.
5. Pavlov VA, Tracey KJ: The cholinergic antiinflammatory pathway. Brain Behav Immun 2005; 19: 493-499.
6. Vezzani A, French J, Bartfai T, Baram TZ: The role of inflammation in epilepsy. Nat Rev Neurol 2011; 7: 31-40.
7. Bernik TR, Friedman SG, Ochani M, Di-Raimo R, Susarla S, Czura CJ, Tracey KJ: Cholinergic antiinflammatory pathway inhibition of tumor necrosis factor during ischemia reperfusion. J Vasc Surg 2002; 36: 1231-1236.
8. Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, Wang H, Abumrad N, Eaton JW, Tracey KJ: Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000; 405: 458-462.
9. Guarini S, Altavilla D, Cainazzo MM, Giuliani D, Bigiani A, Marini H, Squadrito G, Minutoli L, Bertolini A, Marini R, Adamo EB, Venuti FS, Squadrito F: Efferent vagal fibre stimulation blunts nuclear factor-kappaB activation and protects against hypovolemic hemorrhagic shock. Circulation 2003; 107: 1189-1194.
10. Guarini S, Cainazzo MM, Giuliani D, Mioni C, Altavilla D, Marini H, Bigiani A, Ghiaroni V, Passaniti M, Leone S, Bazzani C, Caputi AP, Squadrito F, Bertolini A: Adrenocorticotropin reverses hemorrhagic shock in anesthetized rats through the rapid activation of a vagal anti-inflammatory pathway. Cardiovasc Res 2004; 63: 357-365.
11. Hosoi T, Okuma Y, Nomura Y: Electrical stimulation of afferent vagus nerve induces IL-1beta expression in the brain and activates HPA axis. Am J Physiol Regul Integr Comp Physiol 2000; 279:R141-R147.
12. Huston JM, Gallowitsch-Puerta M, Ochani M, Ochani K, Yuan R, Rosas-Ballina M, Ashok M, Goldstein RS, Chavan S, Pavlov VA, Metz CN, Yang H, Czura CJ, Wang H, Tracey KJ: Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis. Crit Care Med 2007; 35: 2762-2768.
13. Luyer MD, Greve JW, Hadfoune M, Jacobs JA, Dejong CH, Buurman WA: Nutritional stimulation of cholecystokinin receptors inhibits inflammation via the vagus nerve. J Exp Med 2005; 202: 1023-1029.
14. Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, Li JH, Yang H, Ulloa L, Al-Abed Y, Czura CJ, Tracey KJ: Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003; 421: 384-388.
15. Wang H, Liao H, Ochani M, Justiniani M, Lin X, Yang L, Al-Abed Y, Metz C, Miller EJ, Tracey KJ, Ulloa L: Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 2004; 10: 1216-1221.
16. Wu R, Dong W, Cui X, Zhou M, Simms HH, Ravikumar TS, Wang P: Ghrelin down-regulates proinflammatory cytokines in sepsis through activation of the vagus nerve. Ann Surg 2007; 245: 480-486.
17. Corcoran C, Connor TJ, O'Keane V, Garland MR: The effects of vagus nerve stimulation on pro-and anti-inflammatory cytokines in humans: a preliminary report. Neuroimmunomodulation 2005; 12: 307-309.
18. De Herdt V, Bogaert S, Bracke KR, Raedt R, De Vos M, Vonck K, Boon P: Effects of vagus nerve stimulation on pro-and anti-inflammatory cytokine induction in patients with refractory epilepsy. J Neuroimmunol 2009; 214: 104-108.
19. Barone L, Colicchio G, Policicchio D, Di Clemente F, Di Monaco A, Meglio M, Lanza GA, Crea F: Effect of vagal nerve stimulation on systemic inflammation and cardiac autonomic function in patients with refractory epilepsy. Neuroimmunomodulation 2007; 14: 331-336.
20. Majoie HJ, Rijkers K, Berfelo MW, Hulsman JA, Myint A, Schwarz M, Vles JS: Vagus nerve stimulation in refractory epilepsy: effects on pro-and anti-inflammatory cytokines in peripheral blood. Neuroimmunomodulation 2011; 18: 52-56.
21. Boer K, Jansen F, Nellist M, Redeker S, van den Ouweland AM, Spliet WG, van Nieuwenhuizen O, Troost D, Crino PB, Aronica E: Inflammatory processes in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex. Epilepsy Res 2008; 78: 7-21.
22. Choi J, Nordli DR Jr, Alden TD, DiPatri A, Jr., Laux L, Kelley K, Rosenow J, Schuele SU, Rajaram V, Koh S: Cellular injury and neuroinflammation in children with chronic intractable epilepsy. J Neuroinflammation 2009; 6: 38.
23. Ravizza T, Gagliardi B, Noe F, Boer K, Aronica E, Vezzani A: Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol Dis 2008; 29: 142-160.
24. Shu HF, Zhang CQ, Yin Q, An N, Liu SY, Yang H: Expression of the interleukin 6 system in cortical lesions from patients with tuberous sclerosis complex and focal cortical dysplasia type IIb. J Neuropathol Exp Neurol 2010; 69: 838-849.
25. Varella PP, Santiago JF, Carrete H Jr, Higa EM, Yacubian EM, Centeno RS, Caboclo LO, Castro Neto EF, Canzian M, Amado D, Cavalheiro EA, Naffah-Mazzacoratti Mda G: Relationship between fluid-attenuated inversion-recovery (FLAIR) signal intensity and inflammatory mediator's levels in the hippocampus of patients with temporal lobe epilepsy and mesial temporal sclerosis. Arq Neuropsiquiatr 2011; 69: 91-99.
26. Yu N, Di Q, Hu Y, Zhang YF, Su LY, Liu XH, Li LC: A meta-analysis of pro-inflammatory cytokines in the plasma of epileptic patients with recent seizure. Neurosci Lett 2012; 514: 110-115.
27. Sabat R, Grutz G, Warszawska K, Kirsch S, Witte E, Wolk K, Geginat J: Biology of interleukin-10. Cytokine Growth Factor Rev 2010; 21: 331-344.
28. Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, Moshe SL, Perucca E, Wiebe S, French J: Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010; 51: 1069-1077.
29. Dunn L, Dunn L: Peabody Picture Vocabulary Test-III-NL, Nederlandse versie door Liesbeth Schlichting. Amsterdam, Harcourt Assessment, 2005.
30. Beery K, Beery N: The Beery-Buktenica Developmental Test of Visual Motor Integration: Beery VMI-Administration, Scoring and Teaching Manual, ed 5. Minneapolis, NCS Pearson, 2006.
31. Ricker LJ, Kijlstra A, Kessels AG, de Jager W, Liem AT, Hendrikse F, La Heij EC: Interleukin and growth factor levels in subretinal fluid in rhegmatogenous retinal detachment: a case-control study. PLoS One 2011; 6:e19141.
32. Hulkkonen J, Koskikallio E, Rainesalo S, Keranen T, Hurme M, Peltola J: The balance of inhibitory and excitatory cytokines is differently regulated in vivo and in vitro among therapy resistant epilepsy patients. Epilepsy Res 2004; 59: 199-205.
33. Liimatainen S, Fallah M, Kharazmi E, Peltola M, Peltola J: Interleukin-6 levels are increased in temporal lobe epilepsy but not in extra-temporal lobe epilepsy. J Neurol 2009; 256: 796-802.
34. Nowak M, Bauer S, Haag A, Cepok S, Todorova-Rudolph A, Tackenberg B, Norwood B, Oertel WH, Rosenow F, Hemmer B, Hamer HM: Interictal alterations of cytokines and leukocytes in patients with active epilepsy. Brain Behav Immun 2011; 25: 423-428.
35. Alapirtti T, Rinta S, Hulkkonen J, Makinen R, Keranen T, Peltola J: Interleukin-6, interleukin-receptor antagonist and interleukin-1beta production in patients with focal epilepsy: a video-EEG study. J Neurol Sci 2009; 280: 94-97.
36. Lehtimaki KA, Keranen T, Palmio J, Makinen R, Hurme M, Honkaniemi J, Peltola J: Increased plasma levels of cytokines after seizures in localization-related epilepsy. Acta Neurol Scand 2007; 116: 226-230.
37. Bauer S, Cepok S, Todorova-Rudolph A, Nowak M, Koller M, Lorenz R, Oertel WH, Rosenow F, Hemmer B, Hamer HM: Etiology and site of temporal lobe epilepsy influence postictal cytokine release. Epilepsy Res 2009; 86: 82-88.
38. Vezzani A, Conti M, De Luigi A, Ravizza T, Moneta D, Marchesi F, De Simoni MG: Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures. J Neurosci 1999; 19: 5054-5065.
39. Huang ZB, Sheng GQ: Interleukin-1beta with learning and memory. Neurosci Bull 2010; 26: 455-468.
40. Straub RH, Cutolo M, Zietz B, Scholmerich J: The process of aging changes the interplay of the immune, endocrine and nervous systems. Mech Ageing Dev 2001; 122: 1591-1611.
41. Proposal for revised classification of epilepsies and epileptic syndromes-Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1989; 30: 389-399.